Atlas Trials

A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants

Clinical trial NCT06309394 · COMPLETED

Trial details

NCT number
NCT06309394
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2024-05-15
Primary completion
2024-06-04
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.